These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2295072)

  • 1. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
    Paukovits WR; Guigon M; Binder KA; Hergl A; Laerum OD; Schulte-Hermann R
    Cancer Res; 1990 Jan; 50(2):328-32. PubMed ID: 2295072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys: a new synthetic derivative for avoiding dimerization and loss of inhibitory activity.
    Paukovits WR; Hergl A; Schulte-Hermann R
    Mol Pharmacol; 1990 Sep; 38(3):401-9. PubMed ID: 2402229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture.
    Frostad S; Kalland T; Aakvaag A; Laerum OD
    Stem Cells; 1993 Jul; 11(4):303-11. PubMed ID: 8401253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
    Paukovits WR; Paukovits JB; Moser MH; Konstantinov S; Schulte-Hermann R
    Exp Hematol; 1998 Aug; 26(9):851-8. PubMed ID: 9694506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer.
    Paukovits WR; Moser MH; Binder KA; Paukovits JB
    Blood; 1991 Mar; 77(6):1313-9. PubMed ID: 2001454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of hemoregulatory peptide (HP5b) action in culture.
    Laerum OD; Aakvaag A; Frostad S; Kalland T; Langen P; Maurer HR
    Int J Cell Cloning; 1990 Nov; 8(6):431-44. PubMed ID: 2273297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
    Laerum OD; Paukovits WR
    Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
    Pelus LM; King AG; Broxmeyer HE; DeMarsh PL; Petteway SR; Bhatnagar PK
    Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP; Peters WG; Willemze R
    Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK&F108636.
    Veiby OP; LoCastro S; Bhatnagar P; Olsen WM
    Stem Cells; 1996 Mar; 14(2):215-24. PubMed ID: 8991541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in mice.
    Alisauskas RM; Goldenberg DM; Sharkey RM; Blumenthal RD
    Int J Cancer; 1997 Jan; 70(3):323-9. PubMed ID: 9033635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dimer of hemoregulatory peptide (HP5B) stimulates mouse and human myelopoiesis in vitro.
    Laerum OD; Sletvold O; Bjerknes R; Eriksen JA; Johansen JH; Schanche JS; Tveterås T; Paukovits WR
    Exp Hematol; 1988 May; 16(4):274-80. PubMed ID: 3258825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppression.
    Blumenthal RD; Alisauskas R; Lew W; Sharkey RM; Goldenberg DM
    Exp Hematol; 1998 Aug; 26(9):859-68. PubMed ID: 9694507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hemoregulatory peptide pEEDCK may inhibit stem cell proliferation via hydropathic binding to antisense sequence motifs in interleukin-11 and other growth factors.
    Paukovits JB; Rutter R; Ganglberger E; Karlic HI; Marian B; Paukovits WR
    Mol Pharmacol; 1999 Oct; 56(4):665-74. PubMed ID: 10496948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.
    Paukovits WR; Moser MH; Binder KA; Paukovits JB
    Cancer Treat Rev; 1990 Sep; 17(2-3):347-54. PubMed ID: 2272050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and characteristics of colony-forming units fibroblasts (CFU-F) in the bone marrow of weanling mice treated with cytosine arabinoside and phenylhydrazine: correlation with CFU-S, progenitors of diffusion-chamber colonies (CFU-D), and CFU-C.
    Ben-Ishay Z; Borenstein A; Sharon S; Prindull G
    Int J Cell Cloning; 1983 Oct; 1(5):343-59. PubMed ID: 6672102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of high doses of cytosine arabinoside on pluripotent stem cells (CFU-S).
    Guigon M; Izumi-Hisha H; Mary JY
    Exp Hematol; 1989 Feb; 17(2):203-7. PubMed ID: 2912743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-CFU-S quiescence and stem cell exhaustion after cytostatic drug treatment: protective effects of the inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK).
    Paukovits WR; Moser MH; Paukovits JB
    Blood; 1993 Apr; 81(7):1755-61. PubMed ID: 8461461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.